Stereotactic radiotherapy for stage I and II lung cancer: A study of 33 patients;Radiothérapie en conditions stéréotaxiques dans les cancers bronchiques de stades I et II: résultats d'une série de 33 patients

Cancer/Radiotherapie

Volumn 15, Issue 3, 2011, Pages 192-196

  Champeaux Orange, E ^a   Wachter, T ^a   Bouscayrol, H ^a   Barillot, I ^b,c  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b CHU BRETONNEAU   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

Hypofractionation; Lung cancer; Medically inoperable; Stereotactic body frame; Stereotactic radiotherapy

Indexed keywords

ACUTE TOXICITY; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; METASTASIS; OUTCOME ASSESSMENT; PATIENT POSITIONING; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RESPIRATION CONTROL; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; UNITED STATES;

EID: 79956211656     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.10.002     Document Type: Article

References (34)

1. Mountain C.F. A new international staging system for lung cancer. Chest 1986, 89:225S-233S.
2. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988, 96:440-447.
3. Dosoretz D.E., Galmarini D., Rubenstein J.H., Katin M.J., Blitzer P.H., Salenius S.A., et al. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumour eradication. Int J Radiat Oncol Biol Phys 1993, 27:507-516.
4. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of stage I non small cell lung cancer in a geriatric population. Lung Cancer 2001, 32:71-79.
5. Haffty B.G., Goldberg N.B., Gerstley J., Fischer D.B., Peschel R.E. Results of radical radiation therapy in clinical stage I, technically operable non small cell lung cancer. Int J Radiat Oncol Biol Phys 1988, 15:69-73.
6. Krol A.D., Aussems P., Noordijk E.M., Hermans J., Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996, 34:297-302.
7. Sirzen F., Kjellen E., Sorenson S., Cavallin-Stalh E. A systematic overview of radiation therapy effects in non small cell lung cancer. Acta Oncol 2003, 42:493-515.
8. Bellière A., Girard N., Chapet O., Khodri M., Kubas A., Souquet P.J., et al. Irradiation conformationnelle de haute dose dans les cancers bronchiques non à petites cellules localement évolués: étude de faisabilité. Cancer Radiother 2009, 13:298-304.
9. Kong F.M., Hayman J.A., Griffith K.A., Kalemkerian G.P., Arenberg D., Lyons S., et al. Toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006, 65:1075-1086.
10. Timmerman R., Papiez L., McGarry R., Likes L., DesRosiers C., Frost S., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124:1946-1955.
11. McGarry R.C., Papiez L., Williams M., Whitford T., Timmerman R.D. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005, 63:1010-1015.
12. Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., et al. Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101:1623-1631.
13. Wulf J., Haedinger U., Oppitz U., Thiele W., Mueller G., Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a non invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004, 60:186-196.
14. Haasbeek C.J., Lagerwaard F.J., Antonisse M.E., Slotman B.J., Senan S. Stage I non small cell lung cancer in patients aged >75 years. Cancer 2010, 116:406-414.
15. Uematsu M., Shioda A., Suda A., Fukui T., Ozeki Y., Hama Y., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001, 51:666-670.
16. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd R.F., Littles J.F., et al. Dose escalation in non-small-cell lung cancer using three dimensional conformal radiation therapy: update of a phase I trial. JCO 2001, 19:127-136.
17. Ng A.W., Tung S.Y., Wong V.Y. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs. Radiother Oncol 2008, 87:24-28.
18. Noel G., Bollet M.A., Noël S., Feuvret L., Boisserie G., Tep B., et al. Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:1555-1561.
19. Gassa F., Biston M.C., Malet C., Lafay F., Ayadi M., Badel J.N., et al. Principe et mise en oeuvre de la radiothérapie en conditions stéréotaxiques extracrânienne. Cancer Radiother 2006, 10:444-450.
20. Murray B., Forster K., Timmerman R. Frame-based immobilization and targeting for stereotactic body radiation therapy. Med Dosim 2007, 32:86-91.
21. Nagata Y., Takayama K., Matsuo Y., Norihisa Y., Mizowaki T., Sakamoto T., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in four fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
22. Hof H., Herfarth K.K., Münter M., Hoess A., Motsch J., Wannenmacher M., et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003, 56:335-341.
23. Hoyer M., Roed H., Hansen A.T., Ohlhuis L., Petersen J., Nellemann H., et al. Prospective study on stereotactic radiotherapy of limited non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66:S128-S135.
24. Nagata Y., Negoro Y., Aoki, Mizowaki T., Takayama K., Kokubo M., et al. Clinical outcomes of 63D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002, 52:1041-1046.
25. Nyman J., Johansson K.A., Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006, 51:97-103.
26. Xia T., Li H., Sun Q., Wang Y., Fan N., Yu Y., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66:117-125.
27. Chi A., Liao Z., Nguyen N.P., Xu J., Stea B., Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early stage non small cell lung cancer: clinical implications. Radiother Oncol 2010, 94:1-11.
28. Verellen D., Depuydt T., Gevaert T., Linthout N., Tournel K., Duchateau M., et al. Gating and tracking, 4D in thoracic tumours. Cancer Radiother 2010, 14:446-454.
29. Ortholan C., Mornex F. Dose de tolérance à l'irradiation des tissus sains: le poumon. Cancer Radiother 2010, 4-5:312-318.
30. Lagerwaard F.J., Haasbeck C.J.A., Smit E.F., Slotman B.J., Senan S. Outcomes of risk-adapted fractioned stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
31. Senan S., Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current result and new deveopments. Cancer Radiother 2010, 14:115-118.
32. Kimura T., Matsuura K., Murakami Y., Hashimoto Y., Kenjo M., Kaneyasu Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancer: are patients with pulmonary emphysema also candidates for SBRT for lung cancer?. Int J Radiat Oncol Biol Phys 2006, 66:483-491.
33. Henderson M.A., Hoopes D.J., Fletcher J.W., Lin P.F., Tann M., Yiannoutsos C.T., et al. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:789-795.
34. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205.